GB9809350D0 - Novel salt - Google Patents
Novel saltInfo
- Publication number
- GB9809350D0 GB9809350D0 GBGB9809350.3A GB9809350A GB9809350D0 GB 9809350 D0 GB9809350 D0 GB 9809350D0 GB 9809350 A GB9809350 A GB 9809350A GB 9809350 D0 GB9809350 D0 GB 9809350D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel salt
- salt
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Priority Applications (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9809350.3A GB9809350D0 (en) | 1998-05-02 | 1998-05-02 | Novel salt |
HU0102394A HUP0102394A3 (en) | 1998-05-02 | 1999-04-27 | Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl) |
SK1652-2000A SK16522000A3 (en) | 1998-05-02 | 1999-04-27 | Reduced particle size form of 1-(6-chloronaphth-2-ylsulphonyl) -4-[4-(4pyridyl) benzoyl] piperazine |
IL13940599A IL139405A0 (en) | 1998-05-02 | 1999-04-27 | Reduced particle size form of 1-(6-chloronaphth-2-ylsulphonyl)-4-[4-(4-pyridyl) benzoyl] piperazine |
CN99808217A CN1308629A (en) | 1998-05-02 | 1999-04-27 | Reduced partide size form of 1-(6-chloronaphth-2-ylsulphonyl)-4-[4-(4-pyridyl)benzoyl] piperazine |
KR1020007012149A KR20010043216A (en) | 1998-05-02 | 1999-04-27 | Reduced particle size form of 1-(6-chloronaphth-2-ylsulphonyl)-4-[4-(4-pyridyl)benzoyl]piperazine |
PCT/GB1999/001316 WO1999057112A1 (en) | 1998-05-02 | 1999-04-27 | Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl) -4-[4-(4pyridyl) benzoyl] piperazine |
EEP200000638A EE200000638A (en) | 1998-05-02 | 1999-04-27 | Reduced particle size form of 1- (6-chloronaphth-2-ylsulfonyl) -4- [4- (4-pyridyl) benzoyl] -piperazine |
JP2000547082A JP2002513789A (en) | 1998-05-02 | 1999-04-27 | Fine particle size form of 1- (6-chloronaphth-2-ylsulfonyl) -4- [4- (4-pyridyl) benzoyl] piperazine |
CA002331041A CA2331041A1 (en) | 1998-05-02 | 1999-04-27 | Reduced particle size form of 1-(6-chloronaphth-2-ylsulphonyl)-4-¬4-(4pyridyl)benzoyl|piperazine |
EP99919395A EP1084118A1 (en) | 1998-05-02 | 1999-04-27 | Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl) -4- 4-(4pyridyl) benzoyl] piperazine |
PL99343705A PL343705A1 (en) | 1998-05-02 | 1999-04-27 | Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl) -4-[4-(4pyridyl) benzoyl] piperazine |
AU37196/99A AU3719699A (en) | 1998-05-02 | 1999-04-27 | Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl)-4-(4-(4pyridyl)benzoyl) piperazine |
BR9910176-9A BR9910176A (en) | 1998-05-02 | 1999-04-27 | Small particle size of compost, compost, powder, use of a substance, and pharmaceutical composition |
ZA200006036A ZA200006036B (en) | 1998-05-02 | 2000-10-25 | Reduced partice size form of 1-(6-chloronaphth-2-ylsulphonyl)-4-[4-(4-pyridyl) benzoyl] piperazine. |
NO20005498A NO20005498D0 (en) | 1998-05-02 | 2000-11-01 | Form of 1- (6-chloro naphth-2-ysulfonyl) -4- [4- (4-pyridyl) benzoyl] piperazine with reduced particle size |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9809350.3A GB9809350D0 (en) | 1998-05-02 | 1998-05-02 | Novel salt |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9809350D0 true GB9809350D0 (en) | 1998-07-01 |
Family
ID=10831311
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9809350.3A Ceased GB9809350D0 (en) | 1998-05-02 | 1998-05-02 | Novel salt |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1084118A1 (en) |
JP (1) | JP2002513789A (en) |
KR (1) | KR20010043216A (en) |
CN (1) | CN1308629A (en) |
AU (1) | AU3719699A (en) |
BR (1) | BR9910176A (en) |
CA (1) | CA2331041A1 (en) |
EE (1) | EE200000638A (en) |
GB (1) | GB9809350D0 (en) |
HU (1) | HUP0102394A3 (en) |
IL (1) | IL139405A0 (en) |
NO (1) | NO20005498D0 (en) |
PL (1) | PL343705A1 (en) |
SK (1) | SK16522000A3 (en) |
WO (1) | WO1999057112A1 (en) |
ZA (1) | ZA200006036B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1031563B1 (en) | 1997-09-30 | 2005-12-28 | Daiichi Pharmaceutical Co., Ltd. | Sulfonyl derivatives |
TWI290136B (en) | 2000-04-05 | 2007-11-21 | Daiichi Seiyaku Co | Ethylenediamine derivatives |
US7365205B2 (en) | 2001-06-20 | 2008-04-29 | Daiichi Sankyo Company, Limited | Diamine derivatives |
AU2003302238A1 (en) | 2002-12-03 | 2004-06-23 | Axys Pharmaceuticals, Inc. | 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA56197C2 (en) * | 1996-11-08 | 2003-05-15 | Зенека Лімітед | Heterocyclic derivatives |
ATE334975T1 (en) * | 1997-05-30 | 2006-08-15 | Takeda Pharmaceutical | SULFONAMIDE DERIVATIVES, THEIR PRODUCTION AND USE |
EP1031563B1 (en) * | 1997-09-30 | 2005-12-28 | Daiichi Pharmaceutical Co., Ltd. | Sulfonyl derivatives |
-
1998
- 1998-05-02 GB GBGB9809350.3A patent/GB9809350D0/en not_active Ceased
-
1999
- 1999-04-27 JP JP2000547082A patent/JP2002513789A/en active Pending
- 1999-04-27 SK SK1652-2000A patent/SK16522000A3/en unknown
- 1999-04-27 IL IL13940599A patent/IL139405A0/en unknown
- 1999-04-27 BR BR9910176-9A patent/BR9910176A/en not_active IP Right Cessation
- 1999-04-27 CN CN99808217A patent/CN1308629A/en active Pending
- 1999-04-27 CA CA002331041A patent/CA2331041A1/en not_active Abandoned
- 1999-04-27 KR KR1020007012149A patent/KR20010043216A/en not_active Application Discontinuation
- 1999-04-27 EP EP99919395A patent/EP1084118A1/en not_active Withdrawn
- 1999-04-27 EE EEP200000638A patent/EE200000638A/en unknown
- 1999-04-27 AU AU37196/99A patent/AU3719699A/en not_active Abandoned
- 1999-04-27 PL PL99343705A patent/PL343705A1/en not_active Application Discontinuation
- 1999-04-27 WO PCT/GB1999/001316 patent/WO1999057112A1/en not_active Application Discontinuation
- 1999-04-27 HU HU0102394A patent/HUP0102394A3/en unknown
-
2000
- 2000-10-25 ZA ZA200006036A patent/ZA200006036B/en unknown
- 2000-11-01 NO NO20005498A patent/NO20005498D0/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PL343705A1 (en) | 2001-08-27 |
KR20010043216A (en) | 2001-05-25 |
WO1999057112A1 (en) | 1999-11-11 |
AU3719699A (en) | 1999-11-23 |
EP1084118A1 (en) | 2001-03-21 |
CA2331041A1 (en) | 1999-11-11 |
CN1308629A (en) | 2001-08-15 |
EE200000638A (en) | 2002-04-15 |
HUP0102394A2 (en) | 2001-12-28 |
SK16522000A3 (en) | 2001-05-10 |
JP2002513789A (en) | 2002-05-14 |
NO20005498L (en) | 2000-11-01 |
NO20005498D0 (en) | 2000-11-01 |
BR9910176A (en) | 2001-01-09 |
HUP0102394A3 (en) | 2003-01-28 |
ZA200006036B (en) | 2002-01-25 |
IL139405A0 (en) | 2001-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL341642A1 (en) | Novel macrolydes | |
GB9801392D0 (en) | Novel compounds | |
EP1068213A4 (en) | Novel aminoorganofunctionalsiloxanes | |
PL337181A1 (en) | Novel salt | |
PL342295A1 (en) | Paroxetin salts | |
GB9816729D0 (en) | Substituted cyclohexylaminopyrimidines | |
HK1039937A1 (en) | Substituted 3-thiocarbamoylpyrazoles | |
PL347397A1 (en) | Substituted 3-aryl-pyrazoles | |
GB9809350D0 (en) | Novel salt | |
HUP0102476A3 (en) | Substituted cyclooctadepsipeptides | |
HK1039335A1 (en) | Substituted benzoylcyclohexandiones | |
GB9806104D0 (en) | Novel compounds | |
GB9917344D0 (en) | Novel salt | |
GB9810908D0 (en) | Salt selection | |
GB2336840B (en) | Tilidine salt | |
GB9825756D0 (en) | Novel compoundd | |
GB9805049D0 (en) | Solution | |
GB9813572D0 (en) | Solution | |
GB9801608D0 (en) | Camrar II | |
GB9806112D0 (en) | Novel compounds | |
GB9800317D0 (en) | Novel compounds | |
GB9800324D0 (en) | Novel compounds | |
GB9802655D0 (en) | Novel compounds | |
GB9801632D0 (en) | Novel compounds | |
GB9806311D0 (en) | Novel compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |